Target
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Ligand
BDBM118029
Substrate
n/a
Meas. Tech.
Inhibition Assay
pH
7.5±n/a
IC50
49.8±n/a nM
Comments
extracted
Citation
 Cho, HWu, YChoi, C Thiazolidinedione derivative and use thereof US Patent  US8637558 Publication Date 1/28/2014
Target
Name:
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Synonyms:
15-PGDH | 15-hydroxyprostaglandin dehydrogenase [NAD+] | HPGD | PGDH1 | PGDH_HUMAN | Prostaglandin dehydrogenase 1 (15-PGDH) | SDR36C1
Type:
Enzyme
Mol. Mass.:
28974.46
Organism:
Homo sapiens (Human)
Description:
P15428
Residue:
266
Sequence:
MHVNGKVALVTGAAQGIGRAFAEALLLKGAKVALVDWNLEAGVQCKAALDEQFEPQKTLFIQCDVADQQQLRDTFRKVVDHFGRLDILVNNAGVNNEKNWEKTLQINLVSVISGTYLGLDYMSKQNGGEGGIIINMSSLAGLMPVAQQPVYCASKHGIVGFTRSAALAANLMNSGVRLNAICPGFVNTAILESIEKEENMGQYIEYKDHIKDMIKYYGILDPPLIANGLITLIEDDALNGAIMKITTSKGIHFQDYDTTPFQAKTQ
  
Inhibitor
Name:
BDBM118029
Synonyms:
US8637558, 51
Type:
Small organic molecule
Emp. Form.:
C18H21NO3S
Mol. Mass.:
331.429
SMILES:
Cc1cc(C=C2SC(O)=NC2=O)ccc1OCC1CCCCC1 |w:4.3,c:8|
Structure:
Search PDB for entries with ligand similarity: